Back to Treatments

Treatment

Hepatitis A Vaccine (Post-exposure prophylaxis)

1
Conditions
200
Trials
5M
Participants
88%
Average Safety

Condition Evidence

Acute hepatitis A

200 trials · 5M participants

95% effectiveness · 88% safety
Hepatitis A Vaccine (Post-exposure prophylaxis) | DFDA